Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Clinical trial NCT06087458 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06087458
- Sponsor
- Perceive Biotherapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2027-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.